Evolent Health
EVH
187 hedge funds and large institutions have $2.37B invested in Evolent Health in 2018 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 73 increasing their positions, 50 reducing their positions, and 23 closing their positions.
46% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 50
43% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 23
38% more capital invested
Capital invested by funds: $1.71B → $2.37B (+$658M)
5% more funds holding
Funds holding: 178 → 187 (+9)
1.6% more ownership
Funds ownership: 105.6% → 107.19% (+1.6%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
17% less call options, than puts
Call options by funds: $2.34M | Put options by funds: $2.81M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$18.1M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$15.4M |
| 3 |
CCI
Columbus Circle Investors
|
+$13.5M |
| 4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$12.6M |
| 5 |
CM
Castleark Management
Chicago,
Illinois
|
+$11.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$23.9M |
| 2 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
-$23.8M |
| 3 |
FG
Formula Growth
Montreal,
Quebec, Canada
|
-$21.3M |
| 4 |
TIM
Thornburg Investment Management
Santa Fe,
New Mexico
|
-$16M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$13.8M |
EVH Hedge Fund Activity: Q3 2018 in Review
187 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q3 2018, worth a combined $2.37B — up 38% from $1.71B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new EVH positions and 23 closed out — a net gain of 10 holders — while 73 added to existing stakes and 50 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $18.1M. The largest seller was Millennium Management, cutting an estimated $23.9M.
- 187 institutional investors held Evolent Health (EVH) as of Q3 2018, up from 178 in Q2 2018.
- Funds reported $2.37B of Evolent Health stock for Q3 2018, up 38% quarter-over-quarter.
- 33 funds opened new Evolent Health positions in Q3 2018 and 23 closed out, a net change of +10 holders.
- The largest Evolent Health buyer in Q3 2018 was Fidelity Investments, an estimated $18.1M added.
- The largest Evolent Health seller in Q3 2018 was Millennium Management, an estimated $23.9M sold.
Based on aggregated 13F filings for Q3 2018.